期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

NK／T细胞淋巴瘤发病机制的研究进展 被引量：2

Research progress of NK/T cell lymphoma oncogenesis
原文传递
导出
摘要 NK／T细胞淋巴瘤（NKTCL）是好发于中国人群的恶性肿瘤，对传统的非霍奇金淋巴瘤化疗方案反应差，长期生存率极低。近年来，随着对疾病发病机制了解的深入，出现了一些新的有效治疗方案，大大改善了预后。文章就NKTCL发病机制的研究进展进行概述，并介绍相关研究发现在临床实践中的意义。 NK/T cell lymphoma （NKTCL） is an aggressive malignant disease among Chinese. NKTCL is resistant to conventional chemotherapy regimen with poor long-term smvival rate. With new progress about the mechanism of this disease, some novel chemotherapy regimens have been developed and greatly improved the outcome. This review focused on the recent understanding in the field of NKTCL oncogenesis, which may shed light on development of potential therapeutic targets of NKTCL.
作者 赵杨璐(综述) 陶荣(审校)
机构地区 上海交通大学新华临床医学院 上海交通大学医学院附属新华医院血液科
出处 《白血病．淋巴瘤》 CAS 2013年第5期315-317,共3页 Journal of Leukemia & Lymphoma
关键词 淋巴瘤 结外 NK—T细胞 EB病毒 细胞遗传学 研究 Lymphoma, extranodal, NK-T-cell EB virus Cytogentics Research
分类号 R733.4 [医药卫生—肿瘤]
  • 相关文献

参考文献28

  • 1Cho EY, Kim KH, Kim WS, et al. The spectrum of Epstein-Barr virus- associated lymphoproliferative disease in Korea: incidence of disease entities by age groups. J Korean Med Sci, 2008, 23:185-192.
  • 2Zhang Y, Ohyashiki JH, Takaku T, et al. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T- cell lymphoma and chronic active EBV infection. Br J Cancer, 2006, 94: 599-608.
  • 3Kanemitsu N, Isobe Y, Masuda A, et al. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMPI- positive and -negative ENKL. Clin Cancer R es, 2012, 18:2164-2172.
  • 4Pang MF, Lin KW, Peh SC. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer. Cell Mol Biol Lett, 2009, 14: 222-247.
  • 5Nagamine M, Kishibe K, Takahara M, et al. Selected amino acid change encoding Epstein-Barr virus-specific T cell epitope of the LMP2A gene in Japanese nasal NK/T cell lymphoma patients. Intervirology, 2007, 50:319-322.
  • 6Kim do N, Lee SK. Biogenesis of Epstein-Barr virus microRNAs. Mol Cell Bioehem, 2012, 365: 203-210.
  • 7Ramakrishnan R, Donahue H, Garcia D, ct at. Epstein-Ban" virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One, 2011, 6: e27271.
  • 8Motsch N, Alles J, Imig J, et at. MicroRNA profiling of Epstcin-Barr virus-associated NK/T-cell lymphomas by deep sequencing. PLoS One, 2012, 7: e42193.
  • 9Nakashima Y, Tagawa H, Suzuki R, et al. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK/T-cell lymphoma, nasal type. Genes Chromosomes and Cancer, 2005, 44: 247-255.
  • 10Iqbal J, Kucuk C, deLeeuw RJ, et al. Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer cell malignancies. Leukemia, 2009, 23: 1139-1151.

二级参考文献43

  • 1刘恩伊,钟美佐,刘巍,黄进,卢景琛,曾珊.改良SMILE方案治疗ENKTL-NT的临床观察[J].实用癌症杂志,2010,25(5):517-519. 被引量：5
  • 2陈泽程,庞丹梅,叶锡乡,白永红,唐溢聪,梁剑苗,招丽蓉,黄慧强.原发鼻腔T/NK-T细胞非霍奇金淋巴瘤34例临床分析[J].白血病．淋巴瘤,2006,15(1):40-41. 被引量：4
  • 3Jones P A,Laird P W.Cancer epigenetics comes of age[J].Nat Genet,1999,21(2):163-167.
  • 4Herman J G,Baylin S B.Gene silencing in cancer in association with Promoter hypermethylation[J].N Engl J Med,2003,349(21):2042-2054.
  • 5Ito T,Shimada Y,Hashimoto Y,et al.Involvement of TSLC 1 in progression of esophageal squamous cell carcinoma[J].Cancer Res,2003,63(19):6320-6326.
  • 6Guo-Hua Qiu,Luke Ks Tan,Kwok Seng Loh,et al.The candidate tumor suppressor gene BLU,Located at the commonly deleted region 3p21.3,is an E2F-regulated,stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma[J].Oncogene,2004,23(27):4793-4806.
  • 7Leung W K,Yu J,Ng E K,et al.Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues[J].Cancer,2001,91(12):2294-2301.
  • 8Rountree M R,Bachman K E,Herman J G,et al.DNA methylation,chromatin inheritance,and cancer[J].Oncogene,2001,20(24):3156-3165.
  • 9Kuramochi M,Fukuhara H,Nobukuni T,et al.TSLC1 is a tumorsuppressor gene in human non-small-cell lung cancer[J].Nat Genet,2001,27(4):427-430.
  • 10Masuda M,Yageta M,Fukuhara H,et al.The tumor suppressor protein TSLC1 is involved in cell-cell adhesion[J].J Biol Chem,2002,277(34):31014-31019.

共引文献7

同被引文献31

  • 1Henter JI, Home A, Aric6 M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophag0cytic ]ymphohistiocytosis [J]. Pediatr Blood Cancer, 2007, 48: 124-131.
  • 2Quintanilla-Martinez L, Kumar S, Fend F, et al. Fulminant EBV (+) T- cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome[J]. Blood, 2000, 96: 443 -451.
  • 3Young LS, Murray PG. Epstein-Barr virus and oncogenesis: from latent genes to tumours[J]. Oncogene, 2003, 22: 5108-5121.
  • 4Saha A, Robertson ES. Epstein-Barr virus-assoclated B-cell lymphomas: pathogenesis and clinical outcomes[]]. Chn Cancer Res, 2011,17: 3056-3063.
  • 5Roschewski M. EBV-associated lymphomas in adults [J]. Best Pract Res Clin Haematol, 2012, 25: 75-89.
  • 6Quintanilla-Martinez L, Kimura H, Jaffe E, et al. EBV+ T-cell lymphoproliferative disorders of childhood//WHO classification of tumors of hematopoietic and lymphoid tissues[M]. 4th edition. Lyon: IARC, 2008: 278-280.
  • 7Tabanelli V, Agostinelli C, Sabattini E, et al. Systemic Epstein-Barr- virus-positive T cell lymphoproliferative childhood disease in a 22- year-old Caucasian man: a case report and review of the literature[J]. J Med Case Rep, 2011, 5: 218.
  • 8Yoshii M, Ishida M, Hodohara K, et al. Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood: Report of a case with review of the literature[J]. Oncol Lett, 2012, 4: 381-384.
  • 9Cohen JI, Kimura H, Nakamura S, et al. Epstein-Barr virus-associated lymphoproliferative disease in non-immunoeompromised hosts: a status report and summary of an international meeting[J]. Ann Oncol, 2009, 20: 1472-1482.
  • 10Kawa K, Sawada A, Sato M, et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection[J]. Bone Marrow Transplant, 201 I, 46: 77-83,.

引证文献2

二级引证文献4

白血病．淋巴瘤
2013年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部